Formosa Laboratories Inc (TW:4746) — Market Cap & Net Worth
Market Cap & Net Worth: Formosa Laboratories Inc (4746)
Formosa Laboratories Inc (TW:4746) has a market capitalization of $194.36 Million (NT$6.17 Billion) as of June 17, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #16757 globally and #831 in its home market, demonstrating a -2.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Formosa Laboratories Inc's stock price NT$51.30 by its total outstanding shares 120256000 (120.26 Million). Review 4746 total liabilities to assess the company's total debt and financial obligations.
Formosa Laboratories Inc Market Cap History: 2015 to 2026
Formosa Laboratories Inc's market capitalization history from 2015 to 2026. Data shows change from $225.03 Million to $194.36 Million (-0.19% CAGR).
Formosa Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Formosa Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Formosa Laboratories Inc's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.66x
Formosa Laboratories Inc's market cap is 1.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $225.03 Million | $2.60 Billion | $282.39 Million | 0.09x | 0.80x |
| 2016 | $330.75 Million | $3.19 Billion | $483.44 Million | 0.10x | 0.68x |
| 2017 | $238.01 Million | $2.54 Billion | $238.65 Million | 0.09x | 1.00x |
| 2018 | $137.23 Million | $2.69 Billion | $176.82 Million | 0.05x | 0.78x |
| 2019 | $152.01 Million | $2.76 Billion | -$41.06 Million | 0.06x | N/A |
| 2020 | $170.53 Million | $3.08 Billion | $400.03 Million | 0.06x | 0.43x |
| 2021 | $219.75 Million | $3.14 Billion | $1.25 Billion | 0.07x | 0.18x |
| 2022 | $278.47 Million | $3.77 Billion | $216.81 Million | 0.07x | 1.28x |
| 2023 | $386.45 Million | $4.36 Billion | $126.24 Million | 0.09x | 3.06x |
| 2024 | $260.66 Million | $4.73 Billion | $157.27 Million | 0.06x | 1.66x |
Competitor Companies of 4746 by Market Capitalization
Companies near Formosa Laboratories Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Formosa Laboratories Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Formosa Laboratories Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Formosa Laboratories Inc's market cap moved from $225.03 Million to $ 194.36 Million, with a yearly change of -0.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$194.36 Million | -13.49% |
| 2025 | NT$224.67 Million | -13.81% |
| 2024 | NT$260.66 Million | -32.55% |
| 2023 | NT$386.45 Million | +38.78% |
| 2022 | NT$278.47 Million | +26.72% |
| 2021 | NT$219.75 Million | +28.86% |
| 2020 | NT$170.53 Million | +12.19% |
| 2019 | NT$152.01 Million | +10.77% |
| 2018 | NT$137.23 Million | -42.34% |
| 2017 | NT$238.01 Million | -28.04% |
| 2016 | NT$330.75 Million | +46.98% |
| 2015 | NT$225.03 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Formosa Laboratories Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $194.36 Million USD |
| MoneyControl | $194.36 Million USD |
| MarketWatch | $194.36 Million USD |
| marketcap.company | $194.36 Million USD |
| Reuters | $194.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Formosa Laboratories Inc
Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulator… Read more